Comparative effects of a glucocorticosteroid, theophylline and the peptido-leukotriene-antagonist CGP 45715A on antigen-induced early and late phase airway response and inflammatory cell influx in sensitised guinea pigs

European Journal of Pharmacology

Volumn 369, Issue 2, 1999, Pages 225-231

  Heuer, Hubert O ^a   Leon, Indepencia ^a   Anderson, Gary P ^b   Jennewein, Hans Michael ^a  

^a BOEHRINGER INGELHEIM PHARMA GMBH AND CO KG   (Germany)

^b NOVARTIS PHARMA AG   (Switzerland)

Author keywords

Allergic late phase; Bronchoalveolar lavage; CGP 45715A; Cysteinyl leukotriene; Guinea pig; Iralukast; Methylprednisolone; Theophylline

Indexed keywords

GLUCOCORTICOID; IRALUKAST; LEUKOTRIENE RECEPTOR BLOCKING AGENT; METHYLPREDNISOLONE; OVALBUMIN; THEOPHYLLINE;

ALLERGIC REACTION; ANIMAL CELL; ANIMAL MODEL; ARTICLE; CELL COUNT; CONTROLLED STUDY; GUINEA PIG; INFLAMMATORY CELL; INHALATION TEST; LUNG LAVAGE; MALE; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; SENSITIZATION; TIDAL VOLUME;

ANIMALS; BENZOPYRANS; BRONCHIAL PROVOCATION TESTS; BRONCHOALVEOLAR LAVAGE FLUID; BRONCHODILATOR AGENTS; CELL MOVEMENT; CROSS-OVER STUDIES; GUINEA PIGS; HYPERSENSITIVITY; INFLAMMATION; LEUKOCYTES; LEUKOTRIENE ANTAGONISTS; LEUKOTRIENES; MALE; METHYLPREDNISOLONE; THEOPHYLLINE; TIME FACTORS;

EID: 0032993526     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(99)00080-1     Document Type: Article

References (21)

1. Abraham W.M., Sielczak M.W., Wanner A., Perruchoud A.P., Blinder L., Stevenson J.S., Ahmed A., Yerger L.D. Cellular markers of inflammation in the airways of allergic sheep with and without allergen-induced late responses. Am. Rev. Respir. Dis. 138:1988;1565-1571.
2. Bel E.H., Timmers M.C., Dijkman J.H., Stahl E.G., Sterk P.J. The effect of inhaled leukotriene antagonist, L-648,051, on early and late asthmatic reactions and subsequent increase in airway responsiveness in man. J. Allergy Clin. Immunol. 85:1990;1067-1075.
3. 4 antagonist L-649,923 on the response to inhaled antigen in asthma. J. Allergy Clin. Immunol. 79:1987;811-816.
4. Chung K.F., Barnes P.J. Role of inflammatory mediators in asthma. Br. Med. Bull. 48:1992;135-148.
5. Cockcroft D.W., Murdock K.Y. Comparative effects of inhaled salbutamol, sodium cromoglycate, and beclomethasone dipropionate on allergen-induced early asthmatic responses, late asthmatic responses, and increased bronchial responsiveness to histamine. J. Allergy Clin. Immunol. 79:1987;734-740.
6. Dahlén S.-E., Hedqvist P., Hammarström S., Samuelsson B. Leukotrienes are potent constrictors of human bronchi. Nature. 288:1980;484-485.
7. DeMonchy, J.G.R., Kauffman, H.F., Venge, P., Koëter, G.H., de Vries, K., 1986. Bronchoalveolar lavage and the late asthmatic reaction. In: Kay, A.B. (Ed.), Asthma Clinical Pharmacology and Therapeutic Progress. Blackwell Scientific Publications, Oxford, pp. 46-57.
8. Foster A., Chan C.C. Peptide leukotriene involvement in pulmonary eosinophil migration upon antigen challenge in the actively sensitized guinea pig. Int. Arch. Allergy Appl. Immunol. 96:1991;279-284.
9. Gundel R.H., Wegner C.D., Heuer H.O., Letts L.G. A paf receptor antagonist inhibits acute airway inflammation and late-phase responses but not chronic airway inflammation and hyperresponsiveness in a primate model of asthma. Mediators of Inflammation. 1:1992;379-384.
10. Iwama T., Shikada K.I., Yamamoto A., Skashita M., Hibi M., Tanaka S. Effect of NZ-107 on late-phase airway responses and airway hyperreactivity in guinea pigs. Eur. J. Pharmacol. 199:1991;271-278.
11. Larsen G.L. The pulmonary late-phase response. Hos. Pract. 22:1987;155-169.
12. Murphy K.R., Wilson M.C., Irvin C.G., Glezen L.S., Marsh W.R., Haslett C., Henson P.M., Larsen G.L. The requirement for polymorphonuclear leukocytes in the late asthmatic response and heightened airways reactivity in an animal model. Am. Rev. Respir. Dis. 134:1986;62-68.
13. Nakagawa N., Obata T., Kobayashi T., Okada Y., Nambu F., Terawaki T., Furuya T., Muryobayashi K., Sawada M., Aishita H. Effect of a peptide leukotriene receptor antagonist, ONO-1078, on guinea-pig models of asthma. Eur. J. Pharmacol. 235:1993;211-219.
14. Pauwels R., Van Renterghem D., Van Der Straeten M., Johannesson N., Persson C.G.A. The effect of theophylline and enprofylline on allergen-induced brochoconstriction. J. Allergy Clin. Immunol. 76:1985;583-590.
15. Perruchoud A.P., Yerger L., Abraham W.M. Differential effects of aminophylline on the early and late antigen-induced bronchial obstruction in allergic sheep. Am. Rev. Respir. Dis. 129:1984;A282. Suppl.
16. 4 in the early and late pulmonary responses of rats to allergen challenge. Am. Rev. Respir. Dis. 142:1990;353-358.
17. Sasaki H., Yanai M., Shimura S., Okayama H., Aikawa T., Sasaki T., Takishima T. Late asthmatic response to ascaris antigen challenge in dogs treated with metyrapone. Am. Rev. Respir. Dis. 136:1987;1459-1465.
18. Solèr M., Perruchoud A.P., Abraham W.M. Antigen-induced late responses unmasked by indomethacin in allergic sheep are blocked by FPL-55712. Am. Rev. Respir. Dis. 137:1988;178. Suppl.
19. Taylor I.K., O'Shaughnessy K.M., Fuller R.W., Dollery C.T. Effect of cysteinyl-leukotriene receptor antagonist ICI 204,219 on allergen-induced bronchoconstriction and airway hyperreactivity in atopic subjects. Lancet. 337:1991;690-694.
20. Twentyman O.P., Finnerty J.P., Holgate S.T. Effects of inhaled salmeterol (50 μg) on the allergen-induced late asthmatic response and increase in histamine responsiveness. Am. Rev. Respir. Dis. 143:1991;A654. Suppl.
21. 4 with speciical emphasis on CGP 45715A. Drugs of the Future. 16:1991;827-843.